Replies to post #9978 on Herborium Group Inc (HBRM)

[81bob]

Lots of hope, but facts point to deal. This is going up

[livinginstyle]

IMO, there is hope. I have done my DD on this one and made a buy today at .0027. I don't usually trade penny's any more but I do occasionally. I have determined that CHRI is a real company and they grow through acquisition. They want an avenue into the US that eliminates import fees and HBRM is that source. I have a feeling the buy out price could be higher than we have anticipated due to the value and liquidity of the US markets. HBRM sells its products in the United States, the United Kingdom, and continental Europe through a network of distributors, specialty retailers, and e-commerce. This distribution network alone has to be worth a lot of money not even taking HBRM's product line and established sales into consideration. Here is an explanation or a list of HBRM's products that will be available to add to CHRI's product line to be sold everywhere in China and Asia:

Herborium Group, Inc. provides natural and complementary healthcare related products to consumers and healthcare professionals. The company engages in the development, license, and marketing of botanical based medicinal products. It offers dermatology products, which include AcnEase, a herbal medicine product for natural acne and rosacea treatment; and AcnEase Skin Management System for the treatment of acne marks/scars. The company also provides sexual health and performance products that are non-prescriptive alternatives to selected sexual disorders resulting from cardiovascular disease, use of anti-depressants, and even surgical procedures, including hysterectomy. In addition, it offers energy restoration products, such as Lasting Energy, a herbal supplement to combat stress, depletion of energy, jet-lag, and hangover; and for treating overall depletion of energy due to competitive sports, high levels of stress, and extensive sexual activities, as well as other long term or temporary physical demands. Further, the company's products under development include the Liver Activator Series for the treatment of liver damage; ProstAid, an all natural product focused on Benign Prostate Hyperplasia; ProstCare, a product that targets Prostatitis; and CardioVitae, a fermentation based product using a Lucidium derived cell line targeting cardio-pulmonary insufficiencies.